AstraZeneca has commenced construction of its $4.5bn active pharmaceutical ingredient (API) manufacturing facility in Virginia. The site, which is located near Charlottesville, will produce APIs for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback